XYL.NYSEXylem INC

Form 4: Xylem Inc. SVP & General Counsel Dorothy Trefon Capers Reports Stock Transactions

Sentiment:

SEC Form 4


Dorothy Trefon Capers, SVP & General Counsel of Xylem Inc., reports the acquisition and disposal of common stock and derivative securities, including stock options, on March 4th and 5th, 2025.

Summary

  • Dorothy Trefon Capers, SVP & General Counsel of Xylem Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On March 4, 2025, Capers exercised stock options to acquire 7,868 shares at $86.76 and 4,158 shares at $101.09.
  • Also on March 4, 2025, Capers sold 12,026 shares at a weighted average price of $127.2569.
  • On March 5, 2025, Capers was awarded 1,398 restricted stock units and 4,905 non-qualified stock options at a price of $129.67.
  • Following these transactions, Capers directly owns 9,413 shares of common stock and various non-qualified stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions represent a mix of option exercises, stock sales, and new awards. The sale of shares is balanced by the vesting of new options and restricted stock units.

Positives

  • The reporting person was awarded 1,398 restricted stock units and 4,905 non-qualified stock options, indicating continued alignment with the company's long-term success.

Negatives

  • The sale of 12,026 shares could be interpreted negatively, although it may be part of a pre-planned diversification strategy.

Risks

  • Executive stock sales can sometimes be perceived negatively by the market, potentially impacting investor sentiment.

Future Outlook

The reported transactions do not provide specific forward-looking statements, but the vesting schedules of the restricted stock units and stock options extend to March 2028 and March 2035, respectively, suggesting a long-term commitment.

Industry Context

Insider transactions are routinely monitored by investors to gauge executive sentiment and potential future performance. While not necessarily indicative of company performance, significant sales can sometimes raise concerns.

Comparison to Industry Standards

  • Executive compensation packages often include stock options and restricted stock units to align management interests with shareholder value.
  • Vesting schedules of three years are common in the industry to incentivize long-term performance.
  • Comparing the volume and frequency of insider transactions at Xylem to peers like Danaher or Roper Technologies could provide additional context.

Stakeholder Impact

  • The transactions may have a minor impact on shareholder sentiment, depending on how they are interpreted by the market.

Key Dates

DateDescription
2016-02-24Date of amendment and restatement of the Xylem 2011 Omnibus Incentive Plan
2022-03-01Date of option grant that vested in increments on March 1, 2023, March 1, 2024 and March 1, 2025
2023-03-01Date of option grant that vested in increments on March 1, 2024, March 1, 2025 and will vest March 1, 2026
2025-03-04Date of stock option exercises and stock sales
2025-03-05Date of restricted stock unit and non-qualified stock option awards
2026-03-05First vesting date for restricted stock units and non-qualified stock options awarded on March 5, 2025
2027-03-05Second vesting date for restricted stock units and non-qualified stock options awarded on March 5, 2025
2028-03-05Third vesting date for restricted stock units and non-qualified stock options awarded on March 5, 2025
2032-03-01Expiration date for options granted on March 1, 2022
2033-03-01Expiration date for options granted on March 1, 2023
2035-03-05Expiration date for options granted on March 5, 2025

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.